Meningitis
Pneumococcal meningitis dexamethasone treatment mortality risk factors identified
Published in TB and Outbreaks Week, April 25th, 2006
"In experimental meningitis, adjunctive treatment with steroids reduces cerebrospinal fluid inflammation and thereby improves neurological outcome," neurologists in the Netherlands explained. "On the basis of these findings, several clinical trials have assessed treatment with adjunctive steroids in bacterial meningitis, with conflicting results."
"Recently, the results of the European Dexamethasone Study showed a beneficial effect of adjunctive dexamethasone in adults with bacterial meningitis," noted M. Weisfelt and colleagues at...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
More Articles from TB and Outbreaks Week
- Diagnostics
Serum proteomic fingerprints identify SARS cases early during onset - Mycobacterium Tuberculosis
Mycobacterium tuberculosis PE and PPE genes clusters are organized in operons - Proteus Mirabilis
Proteus mirabilis epidemic clones with intra- and interhospital spread identified in Taiwan - Tuberculosis Risk Factors
Pulmonary TB prevalence in gold miners associated with exposure to dust and silica - Virology
Oral oseltamivir and A-322278 effectively reduces influenza viral replication - Alzheimer Disease
HSV-1 in combination with APOE-epsilon 4 confers high risk of Alzheimer disease - More from this issue of TB and Outbreaks Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
